The Self-Administered International Prostate Symptoms Score (IPSS) Questionnaire of Kosovo Men with Benign Prostatic Hyperplasia
- 1 Department of Urology, Clinic of Urology, University Clinical Centre of Kosovo, Pristina, Kosovo
- 2 Department of Nursing and Midwifery, Faculty of Medicine, University of Pristina, Pristina, Kosovo
- 3 Department of Urology, Clinic of Urology, University Clinical Centre of Kosovo, Pristina, Kosovo
Abstract
Background: Benign prostatic hyperplasia (BPH) has been a major health problem for aging males because of its related symptoms and complications. Although it is not a life-threatening condition, BPH has an adverse effect on a patient’s quality of life, as manifested in community and clinical trials. Aim: The aim of the study was the perception of patients in their symptomatology by comparing the place of residence and quality of life in living with HBP using the IPSS questionnaire. Materials and Methods: This was a prospectively designed study conducted at University Clinical Centre of Kosovo—Urology Clinic. The study was conducted from October 2020 to January 2021. The study in criteria was as follows: all patients who presented to the urology outpatient clinic with BPH, Lower Urinary Tract Symptoms (LUTS) and aged > 40 years. The exclusion criteria included the following cases: patients with uncontrolled diabetes (prostate-specific antigen > 4 ng/dL); patients with a history of transurethral resection of the prostate. Results: This study was carried out on 100 consecutive patients with HBP and LUTS attending. The largest proportion of patients 51% was in the 46 - 55 age group. Most patients were between 45 - 65 years of 51%. The largest number of them (52%) was with severe symptoms and 41% of them were with moderate symptoms. Comparing the three levels of IPSS and the quality of life of patients with HBP and LUTS, when asked how they would feel if they still had problems with urination, 22% said they felt upset, analyzing the categorization of patients according to IPSS: mild symptoms were Mean/SD (1.71. ± 1.113), moderate symptoms (2.9 ± 1.49) and severe symptoms (4.31 ± 1.27) p < 0.156. Statistical reliability of 64% p < 0.000 was in patients where they were interested in learning about any invasive option that would allow them to discontinue medication for LUTS. Conclusion: The IPSS is a valid instrument to assess the impact of BPH symptoms on health and quality of life due to urinary symptoms.
- Cornu, J.N., Cussenot, O., Haab, F. and Lukacs, B. (2010) A Widespread Population Study of Actual Medical Management of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia across Europe and beyond Official Clinical Guidelines. European Urology, 58, 450-456. https://doi.org/10.1016/j.eururo.2010.05.045
- Barry, M.J., Fowler Jr., F.J., O’Leary, M.P., Bruskewitz, R.C., Holtgrewe, H.L., Mebust, W.K., et al. (1992) The American Urological Association Symptom Index for Benign Prostatic Hyperplasia. Journal of Urology, 148, 1549-1557. https://doi.org/10.1016/S0022-5347(17)36966-5
- Grossfeld, G.D. and Coakley, FV. (2000) Benign Prostatic Hyperplasia: Clinical Overview and Value of Diagnostic Imaging. Radiologic Clinics of North America, 38, 31-47. https://doi.org/10.1016/S0033-8389(05)70148-2
- Girman, C.J. (1998) Population-Based Studies of the Epidemiology of Benign Prostatic Hyperplasia. British Journal of Urology, 82, 34-43. https://doi.org/10.1046/j.1464-410X.1998.0820s1034.x
- Lepor, H. (2004) Pathophysiology, Epidemiology, and Natural History of Benign Prostatic Hyperplasia. Reviews in Urology, 6, S3-S10. https://doi.org/10.1111/j.1742-1241.2007.01635.x
- Emberton, M., Marberger, M. and De la Rosette, J. (2008) Understanding Patient and Physician Perceptions of Benign Prostatic Hyperplasia in Europe: The Prostate Research on Behaviour and Education (PROBE) Survey. International Journal of Clinical Practice, 62, 18-26. https://doi.org/10.1111/j.1742-1241.2007.01635.x
- Barry, M.J. (2001) Evaluation of Symptoms and Quality of Life in Men with Benign Prostatic Hyperplasia. Urology, 58, 25-32. https://doi.org/10.1016/S0090-4295(01)01300-0
- https://ncusandiego.com/assets/bph-questionnaire.pdf
- McVary, K.T., Roehrborn, C.G., Avins, A.L., Barry, M.J., Bruskewitz, R.C., Donnell, R.F., et al. (2011) Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia. Journal of Urology, 185, 1793-1803. https://doi.org/10.1016/j.juro.2011.01.074
- Ozayar, A., Zumrutbas, A.E. and Yaman, O. (2008) The Relationship between Lower Urinary Tract Symptoms (LUTS), Diagnostic Indicators of Benign Prostatic Hyperplasia (BPH), and Erectile Dysfunction in Patients with Moderate to Severely Symptomatic BPH. International Urology and Nephrology, 40, 933-939. https://doi.org/10.1007/s11255-008-9386-z
- Michael, S. and Stavros, G. (2018) Chapter 3. The Relationship between Inflammation and LUTS/BPH. In: Morgia, G. and Ivan Russo, G., Eds., Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia, Academic Press, Cambridge, 31-50. https://doi.org/10.1016/B978-0-12-811397-4.00003-2